Amylyx Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (4)

Latest Posts

About This Stock More About This Stock
Amylyx Pharmaceuticals - An Emerging Leader In ALS
Article By: Bio Deep Dives
Wednesday, April 12, 2023 9:40 PM EDT
Amylyx has sold off from its earnings report on March 13th. What has been driving this move and what does it mean for the long term prospects of Amylyx?
In this article: AMLX
Read
Amylyx: An "Ice Bucket" Buy
Article By: MoneyShow.com
Sunday, November 6, 2022 3:30 PM EDT
The drug was green-lighted by the Food & Drug Administration last month, after clinical trials partially funded by Ice Bucket Challenge grants showed that Relyvrio takers had a median survival period of 23 months, 4 months more than those on placebo.
In this article: AMLX
Read

Latest Tweets for $AMLX

No tweets yet!

PARTNER HEADLINES